News

Dr. Janko Nikolich-Žugich re-elected as Chair of the Board of the American Aging Association from June 2017 to May 2020

On Saturday, November 19th our Department Head, Dr. Janko Nikolich-Žugich, will be named the Chair of the Biological Section of the Gerontological Society of America (GSA)!


UA Cancer Center Scientist Recognized for ‘Bold Approach to Major Challenges in Biomedical Research’ through NIH Transformative Research Award

Keith Maggert, PhD, with the University of Arizona Cancer Center and associate professor of cellular and molecular medicine, has been awarded a $1.7 million NIH grant and has been recognized for his high-risk/high-reward research that has the potential to change the way we think about epigenetics in disease.


UA Health Sciences Promotes Collaborative Research With Multidisciplinary Program Feasibility Awards

To ensure researchers are competitive in their submission for national research funds to develop cures or new treatments for the world’s most pressing diseases, the UA Health Sciences has awarded four faculty members multidisciplinary program feasibility awards.


UA College of Medicine – Tucson Earns 2016 Health Professions Diversity Award

The college was honored with INSIGHT Into Diversity magazine’s 2016 Health Professions Higher Education Excellence in Diversity (HEED) Award.


Growing up on an Amish Farm Protects Children Against Asthma, UAHS Collaborative Research Shows

House dust differences between Amish and Hutterite communities affect immune development and asthma risk, according to study co-authored by University of Arizona Health Sciences researcher Dr. Donata Vercelli published today in the New England Journal of Medicine.


UA Health Sciences Study of Devastating Lung Disorders in the Critically Ill Receives $11.4 Million Boost

Five-year National Heart, Lung, and Blood Institute program project grant led by UA Vice President for Health Sciences Dr. Joe G.N. “Skip” Garcia


New UAHS Molecular Research Discovery May Translate to New Treatments for a Number of Viral Diseases

Infecting between 50 to 80 percent of the population in the U.S. by the age of 40, the cytomegalovirus, known as CMV, is providing UAHS researchers with answers on how the incurable virus is able to lay dormant and then reactivate to become a life-threatening risk for those with inadequate immune systems.


Boosting Immunity in Older Adults: UA Health Sciences Immunologists Unmask New Infection-Fighting T Cells

Immune-system frailty in adults 65 and older is a widespread public health issue. A study led by the Department of Immunobiology at the University of Arizona College of Medicine – Tucson points to new cells that may hold a solution.


Dr. Gregorio named Vice Dean for Innovation and Development for UA College of Medicine – Tucson

Carol Gregorio, PhD, has been appointed vice dean for innovation and development in the University of Arizona College of Medicine – Tucson (COM-T), effective May 9.


UA Health Sciences’ Colleges Celebrate 2016 Graduates

Fulfilling the health-care needs of Arizona and the nation, nearly 1,000 health sciences degrees will be awarded to University of Arizona Health Sciences students, including medical, nursing, pharmacy and public health graduates, who will be honored at various convocation and commencement ceremonies starting on Monday, May 9 and ending on Saturday, May 14.


UA College of Medicine – Tucson Building Gender Equity for Women in Academic Medicine

Fifteen years after the results of the groundbreaking GRACE Project were released to the media by a group of women faculty at the UA College of Medicine in Tucson, 25 percent of the College’s departments are headed by women and progress continues in creating an environment that enables success for all.


UA College of Medicine – Tucson Recognizes Top Educators

Thirty-sixth annual Faculty Teaching Awards and the Vernon and Virginia Furrow Awards ceremony honored faculty members’ outstanding achievements and excellence in teaching.


UA-Led Research: Prevention of Macular Degeneration Possible

Study published online Nov. 4 in the American Journal of Medicine found that the sight-destroying eye disease is delayed or prevented by l-dopa, used to treat Parkinson’s disease.


Pages